Skip to main content
. 2015 May 27;10:118. doi: 10.1186/s13014-015-0421-9

Fig. 3.

Fig. 3

Brain metastasis progression free survival since the initiation of treatment (n = 96): 54 patients exhibited progressive brain disease after local or systemic treatment. The 2-year brain metastasis progression free survival (BM PFS) was 29.6 %, and the estimated BM PFS time was 17 months